Clinical Deterioration clinical trials

Explore recruiting clinical deterioration clinical trials.

Recruiting clinical deterioration studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Clinical Deterioration trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

SPARE : Evaluation of a therapeutic strategy to reduce the duration of antibiotic therapy for community-acquired alveolar pneumonia in children: a randomized controlled non-inferiority trial

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

OCTAGON:A Phase 4, Single Arm Study to Investigate Oral Corticosteroid Tapering in Adult Patients with Generalized Myasthenia Gravis Treated with Ravulizumab

Italy, Germany

Therapeutic use (Phase IV) EU CTIS Study details

A randomized, placebo-controlled, double-blind, multi-center, phase III trial to assess the efficacy and safety of trimodulin (BT588) in adult hospitalized subjects with CAP including COVID-19 pneumonia.

Belgium, Austria, Slovakia, Germany, Lithuania, Hungary +3 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

“NALPAC” A NON-COMPARATIVE RANDOMIZED PHASE 2 STUDY, EVALUATING THE EFFICACY OF 5-FU + NALIRI AND 5-FU + NALIRINOX FOR METASTATIC PANCREATIC DUCTAL ADENOCARCINOMA (PDAC), PROGRESSIVE AFTER GEMCITABINE-ABRAXANE OR GEMCITABINE MONOTHERAPY.

Belgium

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 2, Randomized, Double-Blinded, Placebo-Controlled, Study to Evaluate Safety, Tolerability, Pharmacometrics, and Efficacy of DNTH103 in Adults with Multifocal Motor Neuropathy (MOMENTUM)

Spain, Italy, Denmark, Poland, France, Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

Phase II, single-arm, open-label interventional clinical trial to evaluate the role of anthracycline infusion after radiotherapy (RT) in pediatric and young adult patients with glioblastoma (pGBM)

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Clinical Deterioration trials by city

Clinical Deterioration in Toronto Clinical Deterioration in Vancouver Clinical Deterioration in Montreal Clinical Deterioration in Calgary Clinical Deterioration in Edmonton Clinical Deterioration in Ottawa Clinical Deterioration in Winnipeg Clinical Deterioration in Quebec City Clinical Deterioration in Hamilton Clinical Deterioration in Kitchener Clinical Deterioration in London Clinical Deterioration in Halifax Clinical Deterioration in New York Clinical Deterioration in Los Angeles Clinical Deterioration in Chicago Clinical Deterioration in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease